Remove 2025 Remove Dosage Remove Vaccines
article thumbnail

BARDA Pulls Plug on Vaxart Oral COVID Vaccine Trial After mRNA Rollback

PharmTech

SHOW MORE The company is not developing an mRNA vaccine, but had been using one as the control in a 10,000-subject Phase IIb trial. 5, 2025, Vaxart, a South San Francisco, Calif. The stop work order was issued despite the trial's Data Safety Monitoring Board allowing continuation without modification.

article thumbnail

Pharmacists Can Simplify the Vaccine Schedule

Pharmacy Times

RSV vaccines are recommended for older adults and those with specific health conditions, with options like Arexvy, mResvia, and Abrysvo available. RSV vaccines are recommended for older adults and those with specific health conditions, with options like Arexvy, mResvia, and Abrysvo available.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

ICH Q6B for Analytics

PharmTech

A magnifying glass examining a vintage vaccine vial surrounded by four minimalistic chart icons, symbolizing healthcare, medicine, and analytics in the context of global health monitoring. Biosimilars continue to build as a sector of this market with an estimated 2025 value in the region of US$42 billion (1). Specifications.

article thumbnail

FDA Mandates Major Opioid Label Revisions to Highlight Long-Term Risks

Pharmacy Times

Suggestions for providers featured in the guidelines include determining if opioids should take place, selecting appropriate dosages, determining prescription length and follow-up, and assessing and reducing risks of misuse, overdose, and opioid use disorder. Published 2025. Accessed August 1, 2025. Published July 31, 2025.

article thumbnail

New Frontline BTK Inhibitor Strategy Gains FDA Approval in Untreated Mantle Cell Lymphoma

Pharmacy Times

On January 16, 2025, the FDA approved acalabrutinib (Calquence; AstraZeneca) in combination with bendamustine and rituximab for the treatment of adult patients with previously untreated mantle cell lymphoma (MCL) who are ineligible for autologous hematopoietic stem cell transplantation (HSCT). January 16, 2025. Cancer Treat Rev.

FDA
article thumbnail

Self-Care Measures for Preventing and Managing Dysmenorrhea

Pharmacy Times

Selection of an appropriate OTC analgesic should take into consideration various patient factors, including the patient’s overall health status, current medical conditions, and medication profile, as well as patient preferences, which are often influenced by dosage form, required dosing intervals, and cost of OTC medication. December 2018.

article thumbnail

Continuous Subcutaneous Lenalidomide Shows Promise in Reducing Toxicity in R/R Multiple Myeloma

Pharmacy Times

Image credit: LASZLO | stock.adobe.com Gabrail et al presented data from a novel strategy involving continuous subcutaneous (SC) infusion of lenalidomide in a poster at the American Association for Cancer Research (AACR) Annual Meeting 2025 in Chicago, Illinois. Subscribe Now!